Aethlon Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January. At present, Aethlon Medical's Total Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 6.1 M, whereas Net Debt is projected to grow to (4.3 M). Key indicators impacting Aethlon Medical's financial strength include:
Investors should never underestimate Aethlon Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aethlon Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Aethlon Medical.
Net Income
(11.6 Million)
Aethlon
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Net Income Per Share
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Operating Cash Flow Sales Ratio
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Price Fair Value
Return On Equity
Cash Conversion Cycle
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
End Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Total Cash From Financing Activities
Change To Liabilities
Change To Account Receivables
Stock Based Compensation
Sale Purchase Of Stock
Change To Inventory
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Other Cashflows From Investing Activities
Change To Netincome
Investments
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Other Stockholder Equity
Total Liab
Total Current Assets
Common Stock
Property Plant And Equipment Net
Accounts Payable
Property Plant And Equipment Gross
Intangible Assets
Short Long Term Debt Total
Current Deferred Revenue
Other Assets
Net Receivables
Inventory
Other Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Property Plant Equipment
Long Term Debt
Non Current Liabilities Total
Net Tangible Assets
Total Permanent Equity
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Capital Surpluse
Additional Paid In Capital
Long Term Debt Total
Short Long Term Debt
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Interest Expense
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Tax Expense
Depreciation And Amortization
Gross Profit
Cost Of Revenue
Income Before Tax
Total Other Income Expense Net
Selling General Administrative
Research Development
Selling And Marketing Expenses
Total Revenue
Net Income From Continuing Ops
Non Operating Income Net Other
Net Income Applicable To Common Shares
Minority Interest
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Aethlon Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aethlon Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Aethlon Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Aethlon Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aethlon Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aethlon Medical's management manipulating its earnings.
Aethlon Medical Stock Summary
Aethlon Medical competes with Tivic Health, Bluejay Diagnostics, Heart Test, Nuwellis, and Bone Biologics. Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Comparative valuation techniques use various fundamental indicators to help in determining Aethlon Medical's current stock value. Our valuation model uses many indicators to compare Aethlon Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aethlon Medical competition to find correlations between indicators driving Aethlon Medical's intrinsic value. More Info.
Aethlon Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Aethlon Medical's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Aethlon Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Aethlon Medical Systematic Risk
Aethlon Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aethlon Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Aethlon Medical correlated with the market. If Beta is less than 0 Aethlon Medical generally moves in the opposite direction as compared to the market. If Aethlon Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aethlon Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aethlon Medical is generally in the same direction as the market. If Beta > 1 Aethlon Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Aethlon Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aethlon Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aethlon Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.0198
At present, Aethlon Medical's Price Earnings To Growth Ratio is projected to increase significantly based on the last few years of reporting.
Aethlon Medical December 20, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aethlon Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aethlon Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aethlon Medical based on widely used predictive technical indicators. In general, we focus on analyzing Aethlon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aethlon Medical's daily price indicators and compare them against related drivers.
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.